Operating
Loss on sale of subsidiary and subsidiaries held for sale
UnitedHealth Group Loss on sale of subsidiary and subsidiaries held for sale increased by 42.9% to -$72.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 380.0%, from -$15.00M to -$72.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalLower is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase indicates the company is divesting assets at a value lower than their book value, potentially signaling poor past performance or strategic restructuring.
Detailed definition
This represents the non-cash accounting loss recognized when a subsidiary or business unit is divested or classified as...
Peer comparison
Common in large conglomerates undergoing portfolio optimization or strategic divestitures.
Metric ID:
operating_loss_on_sale_of_subsidiary_and_subsidiaries_he_5f5d5dHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$7.09B | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +82.7% | +98.4% | +100.0% | — | -173.3% | -102.4% | -51.8% | +42.9% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | +99.8% | +96.7% | -315.0% | — | -380.0% |
Range-$7.09B – $0.00
Avg YoY Growth-124.6%
Median YoY Growth-109.2%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| UnitedHealthcare | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
| Optum Health | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Optum Insight | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Optum Rx | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
Loss on sale of subsidiary and subsidiaries held for sale at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's loss on sale of subsidiary and subsidiaries held for sale?
- UnitedHealth Group (UNH) reported loss on sale of subsidiary and subsidiaries held for sale of -$72.00M in Q1 2026.
- How has UnitedHealth Group's loss on sale of subsidiary and subsidiaries held for sale changed year-over-year?
- UnitedHealth Group's loss on sale of subsidiary and subsidiaries held for sale decreased by 380.0% year-over-year, from -$15.00M to -$72.00M.
- What does loss on sale of subsidiary and subsidiaries held for sale mean?
- The accounting loss recorded from selling or disposing of a business unit.